Clinical Trials Insight: 700028288

Trial Profile

Clinical Trials Insight: 700028288

Phase of Trial: Phase I

Latest Information Update: 04 Mar 2011

At a glance

  • Drugs RH 1 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors Allos Therapeutics
  • Most Recent Events

    • 04 Mar 2011 Results have been published in Annals of oncology: official journal of the European Society for Medical Oncology.
    • 04 Mar 2011 Status changed from not yet recruiting to completed.
    • 16 Nov 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top